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Abstract
The additive contains viable spores of two strains of Bacillus amyloliquefaciens and a single strain of
Bacillus subtilis and is intended to be used with pigs for fattening and minor porcine species at a
minimum inclusion level of 1.5 9 108 colony forming units (CFU)/kg complete feedingstuffs. The two
bacterial species are considered suitable for the qualiﬁed presumption of safety (QPS) approach to
safety assessment, which requires the identity of the strains to be established and evidence that they
lack toxigenic potential and acquired antimicrobial resistance determinants for antibiotics of human and
veterinary importance. The identity of the three active agents is established and the lack of toxigenic
potential conﬁrmed. The two B. amyloliquefaciens strains do not show resistance to relevant
antibiotics, and are presumed safe for the target species, consumers and the environment. The
B. subtilis strain showed a low level of resistance to streptomycin, for which acquired resistance genes
were not identiﬁed. Therefore, it also complies with the QPS qualiﬁcations and is presumed safe for
the target species, consumer and the environment. Since no other component give rise to concerns,
Cinergy® Life B3 HiCon is also considered safe for the target species, consumers and the environment.
In the absence of data, no conclusions can be made on the skin or eye irritancy or the potential for
dermal sensitisation of the additive. Owing to the proteinaceous nature of the active agents, the
additive is considered a potential respiratory sensitiser. However, the low dusting potential makes it
unlikely that additive poses a risk for the respiratory system. Cinergy® Life B3 HiCon showed a
potential to improve the feed to gain ratio in pigs for fattening given the additive at a minimum
inclusion level of 1.5 9 108 CFU/kg complete feed. This conclusion is extrapolated to minor porcine
species at the same application rate and for an equivalent growth phase.
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1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an
application in accordance with Article 7.
The European Commission received a request from Cargill Incorporated, represented By Provimi
Holding BV2 for authorisation of the product Cinergy® Life B3 HiCon (Bacillus amyloliquefaciens NRRL
B-50508, B. amyloliquefaciens NRRL B-50509 and Bacillus subtilis NRRL B-50510) when used as a feed
additive for pigs for fattening and minor porcine species (category: zootechnical additive; functional
group: gut ﬂora stabiliser).
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the
application to the European Food Safety Authority (EFSA) as an application under Article 4(1)
(authorisation of a feed additive or new use of a feed additive). The particulars and documents in
support of the application were considered valid by EFSA as of 8 January 2018.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and
documents submitted by the applicant, shall undertake an assessment in order to determine whether
the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on
the safety for the target animals, consumer, user and the environment and on the efﬁcacy of the
product Cinergy® Life B3 HiCon (Bacillus amyloliquefaciens NRRL B-50508, B. amyloliquefaciens NRRL
B-50509 and Bacillus subtilis NRRL B-50510), when used under the proposed conditions of use (see
Section 3.1.4).
1.2. Additional information
The additive Cinergy® Life B3 HiCon has not been previously authorised as a feed additive in the
EU.
2 Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of a technical
dossier3 in support of the authorisation request for the use of active agent as a feed additive. The
technical dossier was prepared following the provisions of Article 7 of Regulation (EC) No 1831/2003,
Regulation (EC) No 429/20084 and the applicable EFSA guidance documents.
EFSA has veriﬁed the European Union Reference Laboratory (EURL) report as it relates to the
methods used for the control of the active agent in animal feed. The Executive Summary of the EURL
report can be found in Annex A.5
2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and the efﬁcacy of Cinergy® Life
B3 HiCon is in line with the principles laid down in Regulation (EC) No 429/2008 and the relevant
guidance documents: Guidance on zootechnical additives (EFSA FEEDAP Panel, 2012a), Technical
guidance: Tolerance and efﬁcacy studies in target animals (EFSA FEEDAP Panel, 2011), Guidance on
studies concerning the safety of use of the additive for users/workers (EFSA FEEDAP Panel, 2012b),
Guidance on the assessment of the toxigenic potential of Bacillus species used in animal nutrition
(EFSA FEEDAP Panel, 2014), Guidance on the assessment of bacterial susceptibility to antimicrobials of
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 Cargill Incorporated, represented By Provimi Holding BV, Veerlaan 17-23, 3072 AN, Rotterdam, The Netherlands.
3 FEED dossier reference: FAD-2017-0060.
4 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC)
No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications
and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.
5 The full report is available on the EURL website: https://ec.europa.eu/jrc/en/eurl/feed-additives/evaluation-reports/fad-2017-
0060?search&form-return
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human and veterinary importance (EFSA FEEDAP Panel, 2012c) and Guidance on the characterisation
of microorganisms used as feed additives or as production organisms (EFSA FEEDAP Panel, 2018).
3 Assessment
The additive is a preparation containing viable spores of two strains of B. amyloliquefaciens and a
single strain of B. subtilis intended to be used in feed for pigs for fattening and minor porcine species
as a zootechnical additive to improve performance.
3.1 Characterisation
3.1.1. Characterisation of the active agents
All strains are deposited with the United States Department of Agriculture
Agricultural Research Culture Collection (NRRL Collection) with the accession numbers NRRL B-50508
and NRRL 50509 for the two B. amyloliquefaciens strains and NRRL B-50510 for the B. subtilis.7 None
of the strains have been genetically modiﬁed.8
Randomly
ampliﬁed polymorphic DNA (RAPD) PCR genotyping analysis supported the differentiation between the
additive strains and between other similar strains.
No cytotoxic effects were
detected in any of the strains.
(Ohmiya et al., 1989; Kunst et al., 1997)
3.1.2. Characterisation of the additive
The ﬁnal product is a powder with a minimum speciﬁed count of Bacillus spp. is 2.5 9 109 CFU/g
additive with the three strains contributing approximately in equal numbers. Compliance with this
7 Technical dossier/Section II/ Annex II.2.1.2.3.
8 Technical dossier/Section II/ Annex II.2.1.2.1.
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speciﬁcation was demonstrated in ﬁve batches of the additive. The counts given for the individual
strains are the same for all batches
Three batches of the additive were analysed for heavy metals and arsenic, dioxins and dioxin-like
polychlorinated biphenyls (PCBs) and mycotoxins. Lead, cadmium and arsenic were detected at mean
concentrations of 1.8, 0.16 and 0.31 mg/kg additive respectively, while mercury was not detected
(limit of quantiﬁcation (LOQ) < 0.01 mg/kg additive).16 The mean upper bound value for the sum of
dioxins and dioxin-like PCBs was 0.09 ng WHO-PCDD/F-PCB-TEQ/kg additive. These values are
substantially below the maximum levels permitted in feed materials and do not raise concerns. None of
the mycotoxins included in the analysis could be detected (LOQ total aﬂatoxins < 0.05 lg/kg, total
fumonisins < 30 lg/kg, total HT-2 Toxin < 50 lg/kg, total T-2 toxin < 5 lg/kg zearalenone < 25 lg/kg,
ochratoxin < 5 lg/kg and vomitoxin < 50 lg/kg). The same three batches were examined for evidence
of microbial contamination. Coliforms, Escherichia coli, Bacillus cereus and Staphylococcus aureus were
below the detection limits (< 10 CFU/g additive) and no Listeria or Salmonella species could be
isolated from 25 g or 50 g of the additive, respectively.
Sterile culture ﬁltrate obtained from growth of three batches of the additive did not produce zones
of clearing in lawn cultures of a number of test bacterial species indicating that the strains do not
produce extracellular antibacterial activity.17
Particle size distribution using laser diffraction18 and dusting potential by the Stauber–Heubach
method were measured in three batches of additive. The mean particle size was approximately
430 lm with only around 2% (v/v) of particles with diameters < 100 and 0.7% < 10 lm. The dusting
potential reﬂected both the particle size distribution and the inclusion of an unspeciﬁed mineral oil as
binder and gave a mean value of 0.2 g/m3.19
3.1.3. Stability and homogeneity
The shelf-life of the additive was determined by monitoring three batches stored at either 25°C/
60% relative humidity (RH) or 40°C/75% RH for a period of 24 months.20 Essentially no reduction in
total Bacillus count was observed at either temperature.
Three batches of the additive were individually mixed into a commercial vitamin-mineral premix
(containing choline chloride) at a concentration of 1 9 1011 CFU/kg premix and samples taken and
stored in a sealed container for 6 months at 25°C.21 Results showed that numbers of bacilli in the in
the vitamin-mineral premix after 6 months was within 0.5 log10 CFU/g of the time zero count.
Stability in complete feed was investigated using three batches of the additive incorporated into a
typical mash feed for pigs (maize, barley and soybean) and into a pelleted feed of the same
composition (pelleting conditions 95°C for 30 s).22 Samples of the mash and pelleted feed were placed
in sealed foil bags and stored for up to 3 months at 25°C. Counts of total bacilli were made at the
start and after 1 and 3 months. Essentially no reduction in total counts was seen in either the mash
feed or the pelleted feed after pelleting. The effect of pelleting itself, obtained by comparison of the
initial counts of the mash and pelleted feed, was small and less than 0.5 log10 difference.
A total of 10 subsamples were taken from the mash feed after 10 min mixing and analysed for total
bacilli counts.22 Based on the ten samples, the coefﬁcient of variation was 1%, demonstrating
homogeneous mixing.
In the absence of any signiﬁcant reduction in counts in any of the above studies, it is considered
unnecessary to monitor individual strains.
3.1.4. Conditions of use
The product is proposed for use in feed for pigs for fattening and minor porcine species at a
minimum inclusion level of 1.5 9 108 CFU/kg complete feedingstuffs.
16 Technical dossier/Section II/Annex II.1.4.1.1.
17 Technical dossier/Section II/Annex II.1.4.1.2.
18 Technical dossier/Section II/Annex II.1.5.2.
19 Technical dossier/Section II/Annex II.1.5.3.
20 Technical dossier/Section II/Annex II.4.1.1.
21 Technical dossier/Section II/Annex II.4.1.2.
22 Technical dossier/Section II/Annex II.4.1.3.
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3.2. Safety
3.2.1. Safety for target animals, consumers and environment
The bacterial species B. subtilis and B. amyloliquefaciens are considered by EFSA to be suitable for
the qualiﬁed presumption of safety (QPS) approach to safety assessment (EFSA, 2007; EFSA BIOHAZ
Panel, 2017). This approach requires the identity of the strains to be conclusively established and
evidence that the strains lack toxigenic potential and do not show acquired antimicrobial resistance
determinants for antibiotics of human and veterinary importance.
In the view of the FEEDAP Panel, the identity of the three active agents is established and the lack
of toxigenic potential conﬁrmed. The two B. amyloliquefaciens strains do not show resistance to
antibiotics of human and veterinary importance, and therefore, are presumed safe for the target
species, consumers of products derived from animals fed the additive and the environment. The third
strain, B. subtilis NRRL B-50510, showed a low level of resistance to streptomycin, for which acquired
resistance genes were not identiﬁed. Therefore, it also complies with the QPS qualiﬁcations and is
presumed safe for the target species, consumer and the environment. Since the other components of
the additive do not give rise to concerns, Cinergy® Life B3 HiCon is also considered safe for the target
species, consumer and the environment.
3.2.2. Safety for the user
No studies, other than those relating to dust formation, were provided. In the absence of data no
conclusions on skin or eye irritancy or on dermal sensitisation can be made.
Owing to the proteinaceous nature of the active agents, the additive is considered a potential
respiratory sensitiser. The particle size distribution and dusting potential make it unlikely that additive
represents a respiratory hazard.
3.3. Efﬁcacy
3.3.1. Efﬁcacy for pigs for fattening
Four efﬁcacy studies were performed, two in the same Member State and location and two in a
non-EU country.
The ﬁrst two trials were made at the same location using a common design and the same breed of
pig (Table 1) but separated by a 3-month period. The 96 animals (equal numbers of male and female)
in each trial were distributed according to body weight at the start to a total of 32 pens each
containing three animals of the same sex. Sixteen pens (eight male and eight female pens) were
allocated to each of the two treatments – a control group fed the basal diet and a test group given the
basal diet supplemented with 1.5 9 108 CFU bacilli/kg feed. All feeds were analysed for the presence
of bacilli, but results were confused by a high background count. Animals were fed mash diets
containing maize, maize dry distillers grain with solubles (DDGs), wheat middlings and soybean meal in
three phases. The duration of the trials was 96 days for trial 123 and 97 days for trial 2.24 The
parameters recorded were body weight and total pen feed intake at days 0, 42 and the end of the
trial. From these data average daily weight gain, average daily feed intake and feed to gain ratio were
calculated. At the end of the trials all pigs were slaughtered and carcasses evaluated. Data were
analysed by analysis of variance (ANOVA) with the pen as the experimental unit. For performance
data, the model used included dietary treatment, sex, block and the interaction between treatment
and sex as main effects, while for carcass data the model included dietary treatment, sex and the
interaction. Group means were compared using the Dunnett’s test.
In the third trial, 120 pigs (Table 1) were distributed in a randomised block design across 30 pens,
with 15 pens (8 of females and 7 of male barrows) per treatment with four pigs in each pen.25 The
two treatment groups were a control group given mash feeds in three phases based on maize, maize
DDGs and soybean meal and a test group fed the same basal diets supplemented with the additive at
1.5 9 108 CFU/kg diet (conﬁrmed for the test group). The duration of the trial was 111 days. Body
weight measurement and feed consumption per pen were made every 3 weeks or on change of diet
23 Technical dossier/Section IV/Annex IV.3.1.
24 Technical dossier/Section IV/Annex IV.3.2.
25 Technical dossier/Section IV/Annex IV.3.3.
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and from these data average daily gain, average daily feed intake and feed to gain ratio calculated.
Four male and four females per treatment were removed from the trial for a digestibility study (not
reported) and the data arising from the pens from which pigs were removed (2, 3, 17 and 12) were
excluded from the analysis of performance (in the last 2 phases). At the end of the trial 100 pigs were
slaughtered and carcass composition assessed. Data were analysed by ANOVA with the pen as the
experimental unit for performance measurements. For carcass composition data, the individual pig was
used as the experimental unit. For all data, the model included treatment and sex as a ﬁxed effect,
and the interaction of treatment 9 sex.
The fourth trial involved 56 pigs (Table 1) which were distributed in a randomised block design
across 14 pens with seven pens per treatment with four pigs (2 female and 2 male barrows) in each
pen.26 Pigs were introduced into the trial in three batches at weekly intervals to ensure approximately
equal start weights. The two treatment groups were a control group given mash feeds in three phases
based on maize, maize DDGs and soybean meal and a test group fed the same basal diets
supplemented with the additive at 1.5 9 108 CFU/kg diet (conﬁrmed for the test group). The overall
duration of the trial was 109 days but, because of the different start dates, the average duration for
individual animals ranged between 84 and 92 days for the control group and 84 and 93 days for the
treatment group. It is presumed that individual animals were retained on trial until reaching a body
weight of approximately 120 kg. Body weight and feed consumption was recorded at the start, at each
dietary interval and at the end of the trial and from these data average daily gain, average daily feed
intake and feed to gain ratio calculated. The data were analysed by ANOVA with the pen as the
experimental unit. Initial bodyweight was included as a covariate. Group means were compared using
the Tukey’s test.
Table 1: Details on the study design for the studies performed in pigs for fattening
Study
(duration
in days)
Breed
Total animals
replicates/
treatment 3
animals/
replicate
Intended
concentration
in feed
(CFU/kg feed)
Analysed
concentration in
feed
(CFU/kg feed)
Basal diets (main
ingredients) form
1 (96) Pietrain 9 (Landrace 9
Yorkshire)
96
16 9 3
0
1.5 9 108
180/2.1/6.4 9 106
0.7/0.4/1.4 9 108
(maize, maize DDGs,
wheat middlings and
soybean) mash
2 (97) Pietrain 9 (Landrace 9
Yorkshire)
96
16 9 3
0
1.5 9 108
4.0/160/4.0 9 106
0.6/0.3/0.6 9 108
(maize, maize DDGs,
wheat middlings and
soybean) mash
3 (111) PIC Genetiporc 6.0 9
Genetiporc F25
120
15 9 4
0
1.5 9 108
4.5/8.0/1.3 9 106
1.2/1.4/1.0 9 108
(maize, maize DDGs
and soybean meal)
mash
4 (109) (Yorkshire 9 Landrace) 9
Duroc; Yorkshire 9 Duroc
56
7 9 4
0
1.5 9 108
6.3/1.2/1.0 9 106
0.2/2.0/0.3 9 108
(maize, maize DDGs
and soybean meal)
mash
CFU: colony forming unit.
Table 2: Effects of the additive Cinergy® Life B3 HiCon on the performance of pigs for fattening
Trial
no
Additive
(CFU/kg feed)
Initial body
weight (kg)
Feed intake
(kg/day)
Final body
weight (kg)
Daily weight
gain (g/day)
Feed to
gain ratio
1 0 29.9 2.01 107.5 808.2 2.49a
1.5 9 108 29.9 1.96 108.0 813.7 2.41b
2 0 31.6 1.91 105.5 761.8 2.52a
1.5 9 108 31.5 1.89 107.8 778.6 2.43b
3 0 23.5 2.00 129.1 942.0 2.13
1.5 9 108 23.1 1.98 128.9 938.0 2.11
26 Technical dossier/Section IV/Annex IV.3.4 and Supplementary information July 18/Annex II.
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The Panel notes the abnormal high Bacilli counts in one control diet sample in studies 1 and 2. The
applicant justiﬁed these values by a high background contamination and subjected all feed samples to
conﬁrmation of the presence of the active agents. All control feed samples proved negative and the
treated feeds proved positive. Positive refers to a sample in which the majority of the colonies have a
morphology similar to that of the three added Cinergy Life B3 HiCon Bacillus strains. The FEEDAP
Panel does not consider this to be of concern.
No mortalities occurred in either of the ﬁrst two trials, but in trial 2 two animals from the Cinergy
group had to be withdrawn because of ill-health. There were no signiﬁcant differences in growth or
feed intake in either trial but, in both cases, there was a signiﬁcant improvement in feed to gain ratio
(Table 2). No signiﬁcant effects were seen on carcass composition in trial 1 (liveweight, hot carcass,
killing out percentage, % offals, % lean meat). In trial 2, the backfat depth was signiﬁcantly reduced
(15.1 mm vs. 16.7 mm) and lean meat percentage signiﬁcantly increased (61.5% vs. 59.9%) in the
treated group compared to control values.
In the third study, two pigs died during the trial and two were removed (one from each treatment
group in both cases) because of enteric disease. Overall, there were no signiﬁcant differences between
the control and treated groups in performance (Table 2) or carcass composition (not reported).
In the last study, no mortalities occurred and no animals were removed from the trial. Feed intake
was signiﬁcantly lower in the treated group compared to the control animals without an effect on ﬁnal
body weight (Table 2). This led to an improved feed to gain ratio, although the difference did not
reach signiﬁcance.
Since signiﬁcant effects were observed in two studies only, the applicant performed an analysis
pooling the data shown in Table 2, including the effect of the treatment, study and their interaction.
No interactions were found between treatment and study, and a signiﬁcant difference was found for
feed to gain ratio between the treatments (control 2.50 vs. additive 2.43, p = 0.019).27
Conclusions on efﬁcacy
Two of the four individual studies showed a signiﬁcant improvement in feed to gain ratio in favour
of the additive. Pooling of the data from the four studies showed a potential of the additive at a
minimum inclusion level of 1.5 9 108 CFU/kg complete feed to improve the feed to gain ratio of pigs
for fattening.
3.3.2. Efﬁcacy for minor porcine species
Since a potential to improve the feed to gain ratio in pigs for fattening given the additive at the
recommended inclusion level of 1.5 9 108 CFU/kg complete feed was shown, the same conclusion can
be extrapolated to minor porcine species at the same minimum application rate and for an equivalent
growth phase.
3.4. Post-market monitoring
The FEEDAP Panel considers that there is no need for speciﬁc requirements for a post-market
monitoring plan other than those established in the Feed Hygiene Regulation28 and Good
Manufacturing Practice.
4. Conclusions
The three active agents comprising the additive (B. amyloliquefaciens NRRL B-50508 and B-50509
and B. subtilis NRRL B-50510) meet the requirements of the QPS approach to safety assessment and
Trial
no
Additive
(CFU/kg feed)
Initial body
weight (kg)
Feed intake
(kg/day)
Final body
weight (kg)
Daily weight
gain (g/day)
Feed to
gain ratio
4 0 28.9 2.95a 122.2 1030.0 2.86
1.5 9 108 28.5 2.75b 121.9 1030.0 2.68
CFU: colony forming unit.
a,b: Means within a column and study with different superscript letters are signiﬁcantly different at p < 0.05.
27 Technical dossier/Section IV/Annex IV.3.5.
28 Regulation (EC) No 183/2005 of the European Parliament and of the Council of 12 January 2005 laying down requirements for
feed hygiene. OJ L 35, 8.2.2005, p. 1.
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are presumed safe for the target animals, consumers of products derived from animals fed the additive
and the environment. Since the other components of the additive do not give rise to concerns,
Cinergy® Life B3 HiCon is also considered safe for the target species, consumer and the environment.
In the absence of data, no conclusions on skin or eye irritancy or on the potential for dermal
sensitisation can be made. Owing to the proteinaceous nature of the active agents, the additive is
considered a potential respiratory sensitiser. However, the low dusting potential makes it unlikely that
additive poses a risk for the respiratory system.
Cinergy® Life B3 HiCon showed a potential to improve the feed to gain ratio in pigs for fattening at
the minimum inclusion level of 1.5 9 108 CFU/kg complete feed. This conclusion is extrapolated to
minor porcine species at the same application rate and for an equivalent growth phase.
Documentation provided to EFSA
1) Cinergy® Life B3 HiCon. Bacillus amyloliquefaciens AGTP BS918 (NRRL B-50508), Bacillus
amyloliquefaciens AGTP BS1013 (NRRL B-50509), Bacillus subtilis AGTP BS3BP5 (NRRL B-
50510). Zootechnical additive for pigs for fattening and minor porcine species functional
group: gut ﬂora stabiliser. October 2017. Submitted by Cargill Incorporated, represented By
Provimi Holding BV.
2) Cinergy® Life B3 HiCon. Bacillus amyloliquefaciens AGTP BS918 (NRRL B-50508), Bacillus
amyloliquefaciens AGTP BS1013 (NRRL B-50509), Bacillus subtilis AGTP BS3BP5 (NRRL B-
50510). Zootechnical additive for pigs for fattening and minor porcine species functional
group: gut ﬂora stabiliser. Supplementary information. September 2018. Submitted by Cargill
Incorporated, represented By Provimi Holding BV.
3) Evaluation report of the European Union Reference Laboratory for Feed Additives on the
Methods(s) of Analysis for Cinergy® Life B3 HiCon.
4) Comments from Member States.
Chronology
Date Event
30/10/2017 Dossier received by EFSA
16/11/2017 Reception mandate from the European Commission
27/2/2019 Application validated by EFSA – Start of the scientiﬁc assessment
3/4/2018 Reception of the Evaluation report of the European Union Reference Laboratory for Feed
Additives
8/4/2018 Comments received from Member States
31/5/2018 Request of supplementary information to the applicant in line with Article 8(1)(2) of Regulation
(EC) No 1831/2003 – Scientiﬁc assessment suspended. Issues: characterisation and efﬁcacy
16/7/2018 Reception of supplementary information from the applicant – Scientiﬁc assessment re-started
12/9/2018 Request of supplementary information to the applicant in line with Article 8(1)(2) of Regulation
(EC) No 1831/2003 – Scientiﬁc assessment suspended Issues: characterisation
7/12/2018 Reception of supplementary information from the applicant – Scientiﬁc assessment re-started
27/2/2019 Opinion adopted by the FEEDAP Panel. End of the Scientiﬁc assessment
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Abbreviations
ANOVA analysis of variance
BW body weight
CFU colony-forming unit
CG chemical group
CV coefﬁcient of variation
DDGs dry distillers grain with solubles
EURL European Union Reference Laboratory
LOQ limit of quantiﬁcation
MIC minimum inhibitory concentration
PCB polychlorinated biphenyl
PCDD/F polychlorinated dibenzo-p-dioxins and dibenzofurans
PCR polymerase chain-reaction
QPS qualiﬁed presumption of safety
RAPD randomly ampliﬁed polymorphic DNA
RH relative humidity
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Annex A – Executive Summary of the Evaluation Report of the European
Union Reference Laboratory for Feed Additives on the Method(s) of
Analysis for Cinergy® Life B3 HiCon
Cinergy® Life B3 HiCon is the trade name of a preparation based on viable spores of the three non-
genetically modiﬁed strains Bacillus amyloliquefaciens AGTP BS918 (NRRL B-50508), Bacillus
amyloliquefaciens AGTP BS1013 (NRRL B-50509) and Bacillus subtilis AGTP BS3BP5 (NRRL B-50510).
In the current application, authorisation is sought under Article 4(1) for this product under the
category / functional group 4(b) ‘zootechnical additives’ / ‘gut ﬂora stabilisers’, according to Annex I of
Regulation (EC) No 1831/2003. Authorisation is sought for the use of the feed additive for pigs for
fattening and minor porcine species.
The feed additive is to be marketed as a powder containing a minimum content of total active
substances of 2.5 9 109 Colony Forming Unit (CFU)/g. The feed additive is intended to be used
directly in feedingstuffs or through premixtures at a minimum dose of 1.5 9 108 CFU/kg of complete
feedingstuffs.
For the identiﬁcation of Bacillus amyloliquefaciens AGTP BS918, Bacillus amyloliquefaciens AGTP
BS1013 and Bacillus subtilis AGTP BS3BP5, the EURL recommends for ofﬁcial control Pulsed Field Gel
Electrophoresis (PFGE), a generally recognised methodology for genetic identiﬁcation of bacterial
strains.
For the enumeration of all Bacillus spp. strains (AGTP BS918, AGTP BS1013 and AGTP BS3BP5) in
the feed additive, premixtures and feedingstuffs the Applicant submitted the ring-trial validated spread
plate CEN method EN 15784. Based on the performance characteristics available, the EURL
recommends this method for ofﬁcial control.
Further testing or validation of the methods to be performed through the consortium of National
Reference Laboratories as speciﬁed by Article 10 (Commission Regulation (EC) No 378/2005) is not
considered necessary.
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